Red blood cells as a delivery system for AZT
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 2 (1) , 57-61
- https://doi.org/10.3109/10717549509031352
Abstract
3′-Azido-3′-deoxythymidine 5′-phosphate (AZT-MP) was synthesized with the aim of checking whether it represents a prodrug of AZT. AZT-MP was then encapsulated in human erythrocytes by a procedure of hypo-tonic hemolysis and isotonic resealing and found to be dephosphorylated to the corresponding nucleoside (AZT), which was subsequently released outside the red cells. Encapsulated AZT-MP did not interfere with the major metabolic properties of erythrocytes. The dephosphorylation reaction had an apparent Km of 1.6 mM, a pH optimum of 7.4, and was inhibited by 10-5m Pb2+. ATP, TMP, and UMP had no effect on AZT-MP dephosphorylation. AZT permeated the erythrocyte membrane predominantly by nonfacilitated diffusion, but a slow release of AZT-MP was also observed. AZT-MP in human plasma was then dephosphorylated at a rate of 170 nmol/h/ml. Influx of AZT-MP in human erythrocytes was almost undetectable at concentrations below 1 mm. At 2 mri extraerythrocytic AZT-MP influx took place at a rate of 10 nmol/min/ml cells and was not inhibited by the nucleoside transport inhibitors dipyridamole and nitrobenzyl 6-thioinosine. Thus, AZTMP-loaded erythrocytes can perform as a slow delivery system for AZT, potentially avoiding the peaks of drug concentration commonly found after the oral or intravenous administration of nucleoside analogues.Keywords
This publication has 11 references indexed in Scilit:
- Therapy for Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1993
- Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies.Proceedings of the National Academy of Sciences, 1992
- Synthesis and biological evaluation of prodrugs of zidovudineJournal of Medicinal Chemistry, 1990
- Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivityBiochemical and Biophysical Research Communications, 1989
- A pro-drug of zidovudine with enhanced efficacy against human immunodeficiency virusBiochemical and Biophysical Research Communications, 1989
- Reversed-phase liquid chromatographic determination of 2′,3′-dideoxycytidine in human blood samplesJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Conversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes.Proceedings of the National Academy of Sciences, 1988
- 3′-azido-3′-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion.Journal of Biological Chemistry, 1987
- Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.Proceedings of the National Academy of Sciences, 1986
- Identification of thymidine nucleotidase and deoxyribonucleotidase activities among normal isozymes of 5'-nucleotidase in human erythrocytes.Proceedings of the National Academy of Sciences, 1984